a) GFP expression of hippocampal neurons transfected with pCMV-GIN-ZEO.shRNAmirSCR.GFP (SCRmiR). b) Immunofluorescence of phosporylated tau with AT-8 antibody in neurons transfected with SCRmiR expressed in pCMV-GIN-ZEO-GFP plasmid. c) GFP expression of hippocampal neurons transfected with pCMV-GIN-ZEO.shRNAmirCDK5.GFP (CDK5miR). d) Immunofluorescence of phosporylated tau with AT-8 antibody in neurons transfected with CDK5miR; A decrease in AT-8 immunoreactivity was detected. Green: GFP fluorescence, red: Alexa 594. 60×, scale bar: 20 μm. n=4. e) Zoom inserts from b and d. Arrows indicate neuritic processes of transfected cells. The phospho-tau (AT-8) immunoreactivity decrease in neurites transfected with CDK5miR (GFP positive cells). f) Quantification of the fluorescence intensity of AT-8 immunoreactivity in neurons transfected with CDK5miR and SCRmiR, using the software image Scope-Pro (Media cybernetics). RU= Relative Units, n=4, * = p<0,05. g) CDK5, PHF-1, p35, and p25 were evaluated by Western Blotting in neuronal primary cultures transduced with AAV-CDK5miR and AAV-SCRmiR. β-actin was used as loading control. Representative blots are shown. h) Densitometric quantification from g, p25/p35 Ratio was calculated. Data are presented as mean ±S.E.M. p25 and p35 densitometry values were previously normalized to β-actin. n=6, * = p< 0,05. i) CDK5, PHF-1 tau, pSer199 tau and Tau-5 Western blotting from hippocampal lysates of C57BL6 mice injected with LV-CDK5miR and LV-SCRmiR. Representative blots are shown. j) Densitometry of Western blots in LV-CDK5miR and LV-SCRmiR treated mice was measured and normalized to actin. Data is plotted as the percentage of change between control (SCRmiR) and treated (CDK5miR) groups and presented as mean ±S.E.M. n=4, * = p< 0,05, **=p<0,001